The SOPHiA DDM™ Platform will help broaden the hospital’s cancer testing and diagnostic capabilities

BOSTON and ROLLE, Switzerland, May 16, 2024 /PRNewswire/ — SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced that Klinikum Klagenfurt am Wörthersee, the third largest hospital in Austria, is live on the SOPHiA DDM™ Platform. The hospital will use SOPHiA GENETICS’ technology to enhance its next-generation sequencing (NGS) testing and deepen its analytical capabilities for solid tumor and blood cancer (hematology oncology) samples.

Read more at prnewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.